Sign in
CompletedPhase 1/2

Acute Nicotine Gum and Tinnitus Loudness in Non-Smoking Adults

Key facts

Who runs it
San Diego State University
Where
San Diego, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 1/2
People taking part
29 people enrolled
Started
25 Mar 2026
Ended
3 Aug 2026
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Nicotine polacrilex gum 4 mg
  • Placebo gum
Record updated
16 October 2026

Who can take part

Age
18 years to 80 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Non-smoking adult, defined as fewer than 100 cigarettes in a lifetime and none in the past year, with a Fagerstrom Test for Nicotine Dependence score of 2 or less and a negative urinary cotinine test
  • Chronic subjective tinnitus of at least 6 months' duration

Who cannot take part

  • Unstable cardiovascular disease
  • Any condition precluding the psychoacoustic tasks
  • Current or recent tobacco or nicotine use
  • Pregnancy or breastfeeding

Where in United States

  • San Diego State UniversitySan Diego, United States

About the trial

What the trial wants to find out

This study tested whether a single dose of nicotine gum can reduce the loudness of tinnitus (ringing in the ears) in non-smoking adults with chronic tinnitus. Nicotine acts on brain nicotinic acetylcholine receptors that regulate the balance of excitation and inhibition in auditory and attention networks, and may temporarily quiet the phantom sound while improving the ability to focus on relevant sounds. Using a double-blind, placebo-controlled, within-subject crossover design, each participant attended two sessions and received a single 4 mg dose of nicotine polacrilex gum at one session and a flavor-matched placebo gum at the other, in random order. The primary measure was the within-session change in a psychoacoustic match of tinnitus loudness; auditory selective attention was a secondary measure.

The 2 groups in the trial

  • Nicotine gum (4 mg)Treatment being tested

    Single 4 mg dose of nicotine polacrilex gum, chewed for 20 minutes at 1 Hz using the standardized administration protocol.

    Treatment: Nicotine polacrilex gum 4 mg

  • Placebo gumPlacebo, for comparison

    Flavor-, color-, shape-, and texture-matched placebo gum, chewed under the identical protocol.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized, Double-Blind, Placebo-Controlled, Within-Subject Crossover Trial of a Single 4 mg Dose of Nicotine Polacrilex Gum on Psychoacoustic Tinnitus Loudness and Selective Attention in Non-Smoking Adults With Chronic Subjective Tinnitus
Record updated
16 October 2026